This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Subcommittee on Health Discharged.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported Adversely by the Yeas and Nays: 31 - 22.
Reported adversely by the Committee on Energy and Commerce. H. Rept. 117-534.
Reported adversely by the Committee on Energy and Commerce. H. Rept. 117-534.
Placed on the House Calendar, Calendar No. 140.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line